Expanded Access for Pembrolizumab (MK-3475)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nativis Voyager for Newly Diagnosed GBM
- Status
- COMPLETED
- Phase
- NA
Glycemic Impact on Glioblastoma Outcomes
- Status
- WITHDRAWN
- Phase
- N/A
Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
- Status
- UNKNOWN
- Phase
- N/A
Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
- Status
- UNKNOWN
- Phase
- NA
Hypofractionated Radiation Therapy for Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
- Status
- TERMINATED
- Phase
- PHASE3
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
- Status
- COMPLETED
- Phase
- PHASE2
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Engagement of Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
uPAR-PET/MRI in Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE2